VistaGen Therapeutics, Inc.
VTGN · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51 | -$29 | -$59 | -$48 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $2 | $3 | $3 |
| Change in WC | $5 | $1 | $2 | -$2 |
| Other Non-Cash | -$0 | $0 | $4 | $0 |
| Operating Cash Flow | -$42 | -$26 | -$50 | -$45 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | -$1 | $0 |
| Inv. Purchases | -$25 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $12 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$13 | -$0 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1 | -$1 | -$0 |
| Stock Issued | $3 | $129 | $0 | $4 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$945 |
| Other Fin. Act. | $0 | $0 | $0 | $951 |
| Financing Cash Flow | $3 | $128 | -$1 | $10 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$52 | $103 | -$51 | -$35 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $119 | $17 | $68 | $103 |
| End Cash | $67 | $119 | $17 | $68 |
| Free Cash Flow | -$42 | -$26 | -$50 | -$45 |